Vice President and Head of Global Value-based Partnerships
Peter Juhn, MD, MPH is Vice President and Head of Global Value-based Partnerships at Amgen. He is responsible for implementing partnerships with payers, care delivery organizations and other key health care stakeholders that can lead to more clinical improvement opportunities for patients with serious and debilitating illnesses and result in greater overall value for the health care system.
Most recently he was Vice President for Integrated Care Services in the Global Diabetes Division at Sanofi, where he was responsible for creating new patient service platforms and their attendant new business models. He led the business planning efforts for the Sanofi joint venture in diabetes with Verily (aka Google Life Sciences).
Prior to Sanofi, Juhn was at Medco Health Solutions (at the time, the largest PBM with 65 million enrollees) as President of the Therapeutic Resource Centers division, leading a team of over 1000 pharmacists providing medication management support to Medco’s members, and then as Chief Medical Officer of Medco International where he led the delivery of medication support programs for clients in the UK, Germany, Sweden and the Netherlands. Prior to that, he was Vice President of Evidence and Regulatory Policy at Johnson & Johnson, where he was responsible for evidence-based medicine at the J&J Corporate level. He was also Vice President of Health Improvement Resources, at WellPoint Health Networks, where he managed the disease management programs for all its operating units, including Blue Cross of California. He also held senior positions at Kaiser Permanente, including founding head of the Care Management Institute, which is Kaiser’s corporate disease management and clinical policy division, and President and CEO of CareTouch, Inc., an e-health start-up venture.
Juhn has a BA from the University of Chicago, an MD from Harvard Medical School, where he was a Charles A. Dana Foundation Scholar in Clinical Epidemiology, and an MPH from the University of Washington, where he was a Robert Wood Johnson Clinical Scholar. He completed his Internal Medicine residency at the University of Pennsylvania. He was an Instructor in Medicine at the University of Washington, School of Medicine and a Physician at the Seattle Veterans Administration Hospital. He attained Board Certification in Internal Medicine and has a current medical license in California. He served as the industry representative on the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) at the Centers for Medicare and Medicaid Services (CMS), and served two terms on the Effective Health Care Program Stakeholder Group at the Agency for Health Care Research and Quality (AHRQ) in the U.S. Federal Department of Health and Human Services. He was the Coordinator of the manufacturer sector for the Institute of Medicine (IOM) Roundtable on Evidence -based Medicine and edited the manufacturer sector’s statement on EBM in the IOM publication: Leadership Commitments to Improve Value in Health Care.